Mondaca, S., Lebow, E. S., Namakydoust, A., Razavi, P., Reis-Filho, J. S., Shen, R., Offin, M., Tu, H., Murciano-Goroff, Y., Xu, C., Makhnin, A., Martinez, A., Pavlakis, N., Clarke, S., Itchins, M., Lee, A., Rimner, A., Gomez, D., Rocco, G., Chaft, J. E., Riely, G. J., Rudin, C. M., Jones, D. R., Li, M., Shaffer, T., Hosseini, S. A., Bertucci, C., Lim, L. P., Drilon, A., Berger, M. F., Benayed, R., Arcila, M. E., Isbell, J. M., & Li, B. T. (2021). clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. Lung cancer, 159, 66–73. http://access.bl.uk/ark:/81055/vdc_100139616026.0x000053